Xinias Ioannis, Mavroudi Antigoni, Theodorou Georgios-Theofilos, Roilidis Ioannis
Third Pediatric Department, Hippokration Hospital, 54642 Thessaloniki, Greece.
Laboratory of Clinical Neurophysiology, AHEPA University Hospital, Aristotle University of Thessaloniki, 54621 Thessaloniki, Greece.
Infect Dis Rep. 2022 Jan 27;14(1):93-97. doi: 10.3390/idr14010011.
We report our experience regarding a 56-year-old physician who developed severe symptoms mimicking a heart attack a few days after receiving the second dose of the new mRNA vaccine of Pfizer-BioNTech for COVID-19 protection. The patient is a healthy individual with no comorbidities and a normal clinical and laboratory profile. Five days after receiving the second dose on his left shoulder, he manifested sudden, severe pain on the whole left arm which lasted for about one hour, gradually intensifying and migrating to the chest and presenting as severe angina or heart attack. All work-up, however, was negative, with no evidence of ischemic heart attack or myocarditis. Severe acute symptoms lasted for about 20 h and completely resolved after 36 h. Although myocarditis as a potential side effect of the vaccine with associated heart pain has been identified, chest pain mimicking heart attack with otherwise normal workup has not been reported. Physicians must consider this likely rare and self-resolving symptom in order to increase awareness and prevent themselves and their patients from increased anxiety and unnecessary laboratory investigations.
我们报告了一名56岁医生的病例,他在接种辉瑞-生物科技公司用于预防新冠病毒的新型mRNA疫苗第二剂几天后,出现了类似心脏病发作的严重症状。该患者身体健康,无合并症,临床和实验室检查结果均正常。在左肩部接种第二剂疫苗五天后,他突然出现整个左臂剧烈疼痛,持续约一小时,疼痛逐渐加剧并转移至胸部,表现为严重心绞痛或心脏病发作。然而,所有检查结果均为阴性,没有缺血性心脏病发作或心肌炎的证据。严重急性症状持续约20小时,36小时后完全缓解。虽然已确定心肌炎是该疫苗的潜在副作用且伴有心脏疼痛,但此前尚未有检查结果正常却出现类似心脏病发作的胸痛的报道。医生必须考虑到这种可能罕见且可自行缓解的症状,以提高认识,并防止自己和患者出现焦虑加剧以及进行不必要的实验室检查。